• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PCL
Click for more information
0.00% 1.5¢

PANCONTINENTAL ENERGY NL - News & Media

Market Cap $121.9M  ! watchlist Created with Sketch. Add to my watchlist
Energy Oil & Gas E&P

Pancontinental Energy NL is an Australia-based petroleum (oil and gas) exploration... Pancontinental Energy NL is an Australia-based petroleum (oil and gas) exploration company. The Company is focused on conventional oil and gas projects. It has key assets in Africa (Namibia) and Australia (Queensland). The Company’s portfolio includes resource potential, offshore oil projects. The project in Namibia includes Orange Basin PEL 87. The project in Australia includes Onshore Cooper Eromanga Basin, which includes ATP 920 and ATP 924. The Orange Basin PEL 87 is located approximately 10,947 square kilometers in Orange Basin, Offshore Namibia. The ATP 924 is located approximately 2,220 square kilometers in Cooper Eromanga Basin.More

Articles & Videos

Pancontinental Energy (ASX:PCL) more than halfway done with major 3D seismic survey, offshore Namibia

Pancontinental Energy (ASX:PCL) has gathered more than 50 per cent of the data from a major 6872-square-kilometre seismic survey in offshore Namibia.

18 Apr 2023 11:20 (AEST)



(20min delay)
Last
1.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $121.9M
Open High Low Value Volume
1.5¢ 1.6¢ 1.5¢ $20.94K 1.347M

Buyers (Bids)

No. Vol. Price($)
22 5882558 1.5¢
 

Sellers (Offers)

Price($) Vol. No.
1.6¢ 1225750 1
View Market Depth
Last trade - 16.10pm 01/10/2024 (20 minute delay) ?
Last
1.5¢ 		  Change
0.000 ( 6.25 %)
Open High Low Volume
1.6¢ 1.6¢ 1.5¢ 1489313
Last updated 15.29pm 01/10/2024 ?
PCL (ASX) Chart

Top Stories

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Failure to report prompts ASX to impose multiple company suspensions The ASX today told more than 20 companies across many sectors that it would be imposing suspensions on them
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Iress runs 'hot' for Wealth Within's stock tips Financial services software play Iress (ASX:IRE) is the HotCopper Hot Stock tip this week from Wealth Within's chief analyst Dale Gillham and senior analyst Fil Tortevski.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.